BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7942777)

  • 1. Efficient study designs to assess the accuracy of screening tests.
    Irwig L; Glasziou PP; Berry G; Chock C; Mock P; Simpson JM
    Am J Epidemiol; 1994 Oct; 140(8):759-69. PubMed ID: 7942777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avoiding verification bias in screening test evaluation in resource poor settings: a case study from Zimbabwe.
    Gaffikin L; McGrath J; Arbyn M; Blumenthal PD
    Clin Trials; 2008; 5(5):496-503. PubMed ID: 18827042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal designs of two-stage studies for estimation of sensitivity, specificity and positive predictive value.
    McNamee R
    Stat Med; 2002 Dec; 21(23):3609-25. PubMed ID: 12436459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing screening tests: extensions of McNemar's test.
    Lachenbruch PA; Lynch CJ
    Stat Med; 1998 Oct; 17(19):2207-17. PubMed ID: 9802179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel design for estimating relative accuracy of screening tests when complete disease verification is not feasible.
    Alonzo TA; Kittelson JM
    Biometrics; 2006 Jun; 62(2):605-12. PubMed ID: 16918926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weighing gains and losses in criterion validity studies with test-based enrollment.
    Reichenheim ME
    J Clin Epidemiol; 2003 Oct; 56(10):983-8. PubMed ID: 14568630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sequential design to estimate sensitivity and specificity of a diagnostic or screening test.
    Wruck LM; Yiannoutsos CT; Hughes MD
    Stat Med; 2006 Oct; 25(20):3458-73. PubMed ID: 16374904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence estimation when disease status is verified only among test positives: Applications in HIV screening programs.
    G Thomas E; B Peskoe S; Spiegelman D
    Stat Med; 2018 Mar; 37(7):1101-1114. PubMed ID: 29230839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjusting for verification bias in diagnostic accuracy measures when comparing multiple screening tests - an application to the IP1-PROSTAGRAM study.
    Day E; Eldred-Evans D; Prevost AT; Ahmed HU; Fiorentino F
    BMC Med Res Methodol; 2022 Mar; 22(1):70. PubMed ID: 35300611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic test accuracy of nutritional tools used to identify undernutrition in patients with colorectal cancer: a systematic review.
    Håkonsen SJ; Pedersen PU; Bath-Hextall F; Kirkpatrick P
    JBI Database System Rev Implement Rep; 2015 May; 13(4):141-87. PubMed ID: 26447079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing 2-phase prevalence studies in the absence of a "gold standard" test.
    Salim A; Welsh AH
    Am J Epidemiol; 2009 Aug; 170(3):369-78. PubMed ID: 19505999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test result-based sampling: an efficient design for estimating the accuracy of patient safety indicators.
    Taffé P; Halfon P; Ghali WA; Burnand B;
    Med Decis Making; 2012; 32(1):E1-12. PubMed ID: 22065144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity.
    Buderer NM
    Acad Emerg Med; 1996 Sep; 3(9):895-900. PubMed ID: 8870764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating the sampling variation of the disease prevalence when calculating the sample size in a study to determine the diagnostic accuracy of a test.
    Yi Q; Panzarella T; Corey P
    Control Clin Trials; 2004 Aug; 25(4):417-27. PubMed ID: 15296816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study.
    Büscher P; Mertens P; Leclipteux T; Gilleman Q; Jacquet D; Mumba-Ngoyi D; Pyana PP; Boelaert M; Lejon V
    Lancet Glob Health; 2014 Jun; 2(6):e359-63. PubMed ID: 25103304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal two-phase sampling design for comparing accuracies of two binary classification rules.
    Xu H; Hui SL; Grannis S
    Stat Med; 2014 Feb; 33(3):500-13. PubMed ID: 24038175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The latent class model for multiple binary screening tests.
    Lau TS
    Stat Med; 1997 Oct; 16(20):2283-95. PubMed ID: 9351165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How many patients are necessary to assess test performance?
    Arkin CF; Wachtel MS
    JAMA; 1990 Jan; 263(2):275-8. PubMed ID: 2403604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size estimation in diagnostic test studies of biomedical informatics.
    Hajian-Tilaki K
    J Biomed Inform; 2014 Apr; 48():193-204. PubMed ID: 24582925
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.